These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2817851)

  • 1. Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits.
    Merle-Melet M; Seta N; Farinotti R; Carbon C
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1506-10. PubMed ID: 2817851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diclofenac on ceftriaxone pharmacokinetics in humans.
    Merle-Melet M; Bresler L; Lokiec F; Dopff C; Boissel P; Dureux JB
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2331-3. PubMed ID: 1444314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
    Joly V; Pangon B; Brion N; Vallois JM; Carbon C
    J Pharmacol Exp Ther; 1988 Aug; 246(2):695-700. PubMed ID: 3042958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies of biliary ceftriaxone excretion and solubility in guinea pig hepatic bile.
    Purdum PP; Shiffman ML; Moore EW
    J Lab Clin Med; 1992 Oct; 120(4):604-13. PubMed ID: 1402336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.
    Joly V; Pangon B; Vallois JM; Abel L; Brion N; Bure A; Chau NP; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1632-9. PubMed ID: 3324957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile.
    Xia Y; Lambert KJ; Schteingart CD; GU JJ; Hofmann AF
    Gastroenterology; 1990 Aug; 99(2):454-65. PubMed ID: 2365194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora.
    Arvidsson A; Leijd B; Nord CE; Angelin B
    Eur J Clin Invest; 1988 Jun; 18(3):261-6. PubMed ID: 3138129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of PGE2 on hepatic blood flow and bile indocyanin green in the rat.
    Bruck R; Krepel Z; Melzer E; Bar-Meir S
    Prostaglandins; 1989 May; 37(5):531-8. PubMed ID: 2740524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats.
    Hu J; Liu X; Xie L; Wang G; Liu H
    Xenobiotica; 2007 Jun; 37(6):579-91. PubMed ID: 17614005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental evaluation of the biliary tract passage of ceftriaxone and its hepatic disposition].
    Brogard JM; Blickle JF; Jehl F; Dorner M; Monteil H
    Pathol Biol (Paris); 1987 May; 35(5):441-7. PubMed ID: 3302844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pentobarbitone on in-vivo local disposition of diclofenac in rat liver.
    Tabata K; Yamaoka K; Yasui H; Fukuyama T; Nakagawa T
    J Pharm Pharmacol; 1996 Aug; 48(8):866-9. PubMed ID: 8887740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of pentobarbital on biliary excretion of diclofenac in a rat liver perfusion system.
    Fukuyama T; Yamaoka K; Tabata K; Nakagawa T
    J Pharm Pharmacol; 1996 Jul; 48(7):734-7. PubMed ID: 8866339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion of cholephilic organic dyes in glutathione-depleted rats.
    Yoshida H; Kuronuma Y; Iijima M; Harada T
    J Hepatol; 1994 Apr; 20(4):441-5. PubMed ID: 8051379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin-induced reduction in biliary indocyanine green excretion rate in a chronically catheterized rat model.
    Beno DW; Uhing MR; Goto M; Chen Y; Jiyamapa-Serna VA; Kimura RE
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G858-65. PubMed ID: 11292593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hepatic ischaemia/reperfusion injury in a rabbit model of Indocyanine Green clearance.
    Seifalian AM; El-Desoky H; Delpy DT; Davidson BR
    Clin Sci (Lond); 2002 May; 102(5):579-86. PubMed ID: 11980578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary excretion of organic anions in diabetic rats.
    Watkins JB; Noda H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):467-73. PubMed ID: 2430094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of bromosulphophthalein, indocyanine green and bilirubin on the biliary excretion of methylmercury.
    Magos L; Clarkson TW; Allen J; Snowden R
    Chem Biol Interact; 1979 Aug; 26(3):317-20. PubMed ID: 509694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy.
    Hayton WL; Schandlik R; Stoeckel K
    Eur J Clin Pharmacol; 1986; 30(4):445-51. PubMed ID: 3743620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High biliary elimination of ceftriaxone in man.
    Brogard JM; Blickle JF; Jehl F; Arnaud JP; Paris-Bockel D; Monteil H
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):167-72. PubMed ID: 3403093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.